Email Alert RSS
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2024  > 
WANG Yajuan, WANG Yuan, REN Xinyu. Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0454
Citation: WANG Yajuan, WANG Yuan, REN Xinyu. Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0454
shu

Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer

doi: 10.12290/xhyxzz.2023-0454

  • 1 Department of Pathology, Longfu Hospital of Beijing, Beijing 100010, China;

  • 2 Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds:

National High Level Hospital Clinical Research Funding 2022-PUMCH-C-057)

  • Received Date: 2023-09-26
  • Accepted Date: 2023-11-22
    • Available Online: 2024-04-24
    Abstract
  • Objective To investigate the expression of CD117 and DOG1 in triple negative breast cancer (TNBC) and to explore their relationship with clinicopathologic features and prognosis. Methods The patients with TNBC in Peking Union Medical College Hospital from 2000 to 2011 were retrospectively collected and tissue microarrays were made. The expression of CD117 and DOG1 in tumor cells was detected by immunohistochemistry to analyze their relationship with the clinicopathological characteristics of the patients, such as age, tumor diameter, American Joint Committee on Cancer (AJCC) cancer stage, histological grade, P53, and Ki-67 proliferation index, and explore the effect of both on the survival of patients. Results A total of 185 TNBC patients meeting the inclusion and exclusion criteria were selected, of which 24 (12.97%) were CD117 positive and 22 (11.89%) were DOG1 positive, with a co-expression rate of 1.62%. Compared with CD117-negative patients, CD117-positive patients had higher Ki-67 proliferation index (87.50% vs. 67.70%, P=0.048), basal-like TNBC (95.83% vs. 74.53%, P=0.020), and P53 diffuse positive (33.33% vs. 13.66%, P=0.032). Compared with DOG1-negative patients, DOG1-positive patients had lower proportions of tumor diameter ≤ 2cm (22.73% vs. 45.40%, P=0.026) and basal-like TNBC (54.55% vs. 80.37%, P=0.015). The median follow-up was 71 months (range:2-170 months), 4 cases (2.16%) were lost to follow-up, 66 cases (35.68%) relapsed or had distant metastasis, and 34 cases (18.38%) died. Survival analysis showed that AJCC stage (HR=7.624, 95%CI:2.187-26.576, P=0.001) and CD117 positive with P53 diffuse strong positive (HR=3.942, 95%CI:1.366-11.379, P=0.011) were negatively correlated with the overall survival of TNBC patients. Conclusion The expression of CD117 and DOG1 were significantly related to basal-like TNBC, CD117 positive with P53 diffuse strong positive may be correlated with a shorter overall survival and a higher mortality risk.
    • FullText(HTML)
  • loading
    • References(16)
  • [1] Borri F, Granaglia A. Pathology of triple negative breast cancer[J]. Semin Cancer Biol, 2021, 72:136-145.
    [2] Funkhouser A T, Strigenz A M, Blair B B, et al. KIT mutations correlate with higher galectin levels and brain metastasis in breast and non-small cell lung cancer[J]. Cancers (Basel), 2022, 14(11):2781.
    [3] Roskoski R, Jr. Properties of FDA-approved small molecule protein kinase inhibitors:a 2023 update[J]. Pharmacol Res, 2023, 187:106552.
    [4] Luo Y L, Huang W T, Zhang H Z, et al. Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer[J]. Oncol Lett, 2018, 15(5):6161-6170.
    [5] Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity[J]. Science, 2008, 322(5901):590-594.
    [6] Bae J S, Park J Y, Park S H, et al. Expression of ANO1/DOG1 is associated with shorter survival and progression of breast carcinomas[J]. Oncotarget, 2017, 9(1):607-621.
    [7] Jansen K, Farahi N, Büscheck F, et al. DOG1 expression is common in human tumors:a tissue microarray study on more than 15,000 tissue samples[J]. Pathol Res Pract, 2021, 228:153663.
    [8] Nielsen T O, Leung S C Y, Rimm D L, et al. Assessment of Ki67 in breast cancer:updated recommendations from the international Ki67 in breast cancer working group[J]. J Natl Cancer Inst, 2021, 113(7):808-819.
    [9] Rakha E A, Ellis I O. Triple-negative/basal-like breast cancer:review[J]. Pathology, 2009, 41(1):40-47.
    [10] Sheikh E, Tran T, Vranic S, et al. Role and significance of c-KIT receptor tyrosine kinase in cancer:a review[J]. Bosn J Basic Med Sci, 2022, 22(5):683-698.
    [11] Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16):5367-5374.
    [12] Schulmeyer C E, Fasching P A, Häberle L, et al. Expression of the immunohistochemical markers CK5, CD117, and EGFR in molecular subtypes of breast cancer correlated with prognosis[J]. Diagnostics (Basel), 2023, 13(3):372.
    [13] Kriegsmann K, Flechtenmacher C, Heil J, et al. Immunohistological expression of SOX-10 in triple-negative breast cancer:a descriptive analysis of 113 samples[J]. Int J Mol Sci, 2020, 21(17):6407.
    [14] Mitri Z I, Abuhadra N, Goodyear S M, et al. Impact of TP53 mutations in triple negative breast cancer[J]. NPJ Precis Oncol, 2022, 6(1):64.
    [15] Pan Y B, Yuan Y F, Liu G S, et al. P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients[J]. PLoS One, 2017, 12(2):e0172324.
    [16] Jansson S, Bendahl P O, Grabau D A, et al. The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer[J]. PLoS One, 2014, 9(7):e102176.
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (9) PDF downloads(1) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return